NDC product
Estradiol / Norethindrone Acetate
NDC 51991-623 · Breckenridge Pharmaceutical, Inc.
Key facts
| Product NDC | 51991-623 |
|---|---|
| Proprietary name | Estradiol / Norethindrone Acetate |
| Nonproprietary name | Estradiol and Norethindrone Acetate |
| Substances | ESTRADIOL, NORETHINDRONE ACETATE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA078324 |
| Pharmacologic classes | Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC] |
| Marketing start | Jun 9, 2011 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: